Kardiovaskulär risk bör skattas regelbundet vid inflammatorisk systemsjukdom: Reumatologföreningen har utarbetat riktlinjer för primärprevention

Lakartidningen

Volumn 109, Issue 1-2, 2012, Pages 27-29

  Jonsson, Solveig Wållberg ^f   Ljung, Lotta ^a   D'Elia, Helena Forsblad ^b   Henrohn, Dan ^c   Turesson, Carl ^d   Svenungsson, Elisabet ^e  

^a UMEÅ UNIVERSITY   (Sweden)

^b SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^c UPPSALA UNIVERSITY   (Sweden)

^d LUND UNIVERSITY HOSPITAL   (Sweden)

^e KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^f NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84856185920     PISSN: 00237205     EISSN: 16527518     Source Type: Journal    
DOI: None     Document Type: Note

References (20)

1. Aviña-Zubieta JA, Choi HK, Sadatsafavi M, Etminan M, Esdaile JM, Lacaille D. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59:1690-7.
2. Del Rincon I, Williams K, Stern MP, Gregory L, Freeman GL, Escalante A. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2737-45.
3. Jonsson SW, Backman C, Johnson O, Karp K, Lundström E, Sundqvist KG, et al. Increased prevalence of atherosclerosis in patients with medium term rheumatoid arthritis. J Rheumatol. 2001;28: 2597-602.
4. Svenungsson E, Jensen-Urstad K, Heimburger M, Silveira A, Hamsten A, de Faire U, et al. Risk factors for cardiovascular disease in systemic lupus erythematosus. Circulation. 2001;104:1887-93.
5. Björnådal L, Baecklund E, Yin L, Granath F, Klareskog L, Ekbom A. Decreasing mortality in patients with rheumatoid arthritis: Results from a large population based cohort in Sweden, 1964-95. J Rheumatol. 2002;29:906-12.
6. Esdaile JM, Abrahamowicz M, Grodzicky T, Li Y, Panaritis C, du Berger R, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001; 44(10):2331-7.
7. Peters MJ, van der Horst-Bruinsma IE, Dijkmans BA, Nurmohamed MT. Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis. Semin Arthritis Rheum. 2004;34:585-92.
8. Wållberg-Jonsson S, Johansson H, Öhman ML, Rantapää-Dahlqvist S. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol. 1999;26:2562-71.
9. Gustafsson J, Gunnarsson I, Börjesson O, Pettersson S, Möller S, Fei GZ, et al. Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort study. Arthritis Res Ther. 2009;11(6): R186. doi:10.1186/ar2878
10. Gonzales A, Maradit Kremers H, Crowson CS, Ballman KV, Roger VL, Jacobsen SJ, et al. Do cardiovascular risk factors confer the same risk for cardiovascular outcomes in rheumatoid arthritis patients as in non-rheumatoid arthritis patients? Ann Rheum Dis. 2008;67:64-9.
11. Turesson C, McClelland RL, Christianson TJH, Matteson EL. Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis. Ann Rheum Dis. 2007;66:70-5.
12. del Rincon I, Freeman GL, Haas RW, O'Leary DH, Escalante A. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 2005;52:3413-23.
13. Choi HK, Hernán MA, Seeger JD, Robins JM, Woolfe F. Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet. 2002;359:1173-7.
14. Jacobsson LT, Turesson C, Gülfe A, Crnkic M, Petersson IF, Saxne T, et al. Low incidence of first cardiovascular event in rheumatoid arthritis patients treated with TNF-blockers. J Rheumatol. 2005; 32:1213-8.
15. http://www.svenskreumatologi.se
16. Wilhelmsen L, Wedel H, Conroy R, Fitzgerald T. Det svenska SCOREdiagrammet för kardiovaskulär risk. Läkartidningen. 2004;101: 1798-801.
17. http://www.lakemedelsverket.se
18. http://www.inlinedss.se/evibase
19. http://www.heartscore.org
20. Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69 (2):325-31.